Rezolute, Inc. - Common Stock, par value $0.001 per share (RZLT)

CUSIP: 76200L309

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 6 signals
Share change
+5,062,800
SEC-reported price per share
$0.99
Indexed holders
31
Value change
+$4,794,203
Number of buys
13
Number of sells
7
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
118,102,557

Security key

76200L309

Report period

Q4 2023

Indexed institutions

31

Top holders

10

Ownership snapshot

Top reported holders of RZLT - Rezolute, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Genexine Inc.
Disclosed value leader
Genexine Inc.
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5 13F Highest disclosed value: $173,462,643 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Genexine Inc. has the largest disclosed position value at $173.46M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Genexine Inc.'s linked filing trail.
Disclosed position value Top 5
Genexine Inc. $173.46M
HANDOK, INC. $10.05M
FEDERATED HERMES, INC. $8.73M
FIRST MANHATTAN CO. LLC. $4.78M
Stonepine Capital Management, LLC $4.06M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Genexine Inc.
3/4/5
10%+ Owner
—
denominator unverified
$173,462,643
91,300,933 shares
— 26 Apr 2019
HANDOK, INC.
3/4/5
Director, 10%+ Owner
—
denominator unverified
$10,051,937
5,942,617 shares
— 15 Oct 2021
FEDERATED HERMES, INC.
13F
Company
13F
—
denominator unverified
$8,725,562
6,610,274 shares
— 30 Sep 2023
FIRST MANHATTAN CO. LLC.
13F
Company
13F
—
denominator unverified
$4,782,462
3,623,078 shares
— 30 Sep 2023
Stonepine Capital Management, LLC
13F
Company
13F
—
denominator unverified
$4,055,668
3,072,476 shares
— 30 Sep 2023
Blackstone Inc.
13F
Company
13F
—
denominator unverified
$2,029,743
1,537,684 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
31
Shares
28,952,301
Indexed holders
31
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 indexed holders
29
Q4 2023 indexed holders
31
Indexed holder difference
2
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .